Table 5.

Representativeness of Community Counts registry participants as a proportion of all patients treated at HTCs

DiagnosisSeverityMidwestNortheastSoutheastWest
Registry CC patient countHTC PP patient count%Registry CC patient countHTC PP patient count%Registry CC patient countHTC PP patient count%Registry CC patient countHTC PP patient count%
Hem A Severe 6530 16138 40.5 4219 11453 36.8 7726 21793 35.5 3786 15202 24.9 
 Moderate 1585 4709 33.7 1271 3970 32.0 2205 6250 35.3 1090 5361 20.3 
 Mild 2492 9915 25.1 1722 7286 23.6 2245 9107 24.7 1405 9403 14.9 
Total all Hem A 10607 30762 34.5 7212 22709 31.8 12176 37150 32.8 6281 29966 21.0 
Hem B Severe 1216 2944 41.3 735 2089 35.2 1236 3517 35.1 578 2815 20.5 
 Moderate 1565 6453 24.3 503 2281 22.1 876 2853 30.7 442 2110 20.9 
 Mild 798 4574 17.4 358 2105 17.0 765 3099 24.7 263 1939 13.6 
Total all Hem B 3579 13971 25.6 1596 6475 24.6 2877 9469 30.4 1283 6864 18.7 
DiagnosisSeverityMidwestNortheastSoutheastWest
Registry CC patient countHTC PP patient count%Registry CC patient countHTC PP patient count%Registry CC patient countHTC PP patient count%Registry CC patient countHTC PP patient count%
Hem A Severe 6530 16138 40.5 4219 11453 36.8 7726 21793 35.5 3786 15202 24.9 
 Moderate 1585 4709 33.7 1271 3970 32.0 2205 6250 35.3 1090 5361 20.3 
 Mild 2492 9915 25.1 1722 7286 23.6 2245 9107 24.7 1405 9403 14.9 
Total all Hem A 10607 30762 34.5 7212 22709 31.8 12176 37150 32.8 6281 29966 21.0 
Hem B Severe 1216 2944 41.3 735 2089 35.2 1236 3517 35.1 578 2815 20.5 
 Moderate 1565 6453 24.3 503 2281 22.1 876 2853 30.7 442 2110 20.9 
 Mild 798 4574 17.4 358 2105 17.0 765 3099 24.7 263 1939 13.6 
Total all Hem B 3579 13971 25.6 1596 6475 24.6 2877 9469 30.4 1283 6864 18.7 

The table displays all patients with hemophilia aged ≥2 years when enrolling into the CC surveillance system from 2013 to 2023

CC, Community Counts, a more detailed prospective registry; Hem, hemophilia; HTC/PP, population profile, all participants treated at the HTC.

Boldface numbers indicate cumulative counts and percentages for Hem A and Hem B participants, respectively, in each of the 4 regions.

or Create an Account

Close Modal
Close Modal